Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health

Author： Journé Fabrice   Body Jean-Jacques   Leclercq Guy   Laurent Guy  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.7, Iss.3, 2008-05, pp. : 241-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging data on the efficacy and safety of fulvestrant, a unique antiestrogen therapy for advanced breast cancer

By Scott Sarah M   Brown Myles   Come Steven E  

Expert Opinion on Drug Safety, Vol. 10, Iss. 5, 2011-09 ,pp. : 819-826

Informa Healthcare

Access to resources Recommend Favorite

Fulvestrant: A Review of its Use in Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women with Disease Progression following Antiestrogen Therapy

By McKeage K.   Curran M.P.   Plosker G.L.  

Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. : 633-648

Adis International

Access to resources Recommend Favorite

Fulvestrant extends hormonal therapy options in breast cancer

By  

Inpharma, Vol. 1, Iss. 1473, 2005-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Fulvestrant - A Novel Endocrine Therapy for Breast Cancer

By  

Current Medicinal Chemistry, Vol. 17, Iss. 10, 2010-04 ,pp. : 902-914

Bentham Science Publishers

Access to resources Recommend Favorite

Fulvestrant – a new treatment for postmenopausal women with hormone-sensitive advanced breast cancer

By Possinger Kurt  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2549-2558

Informa Healthcare

Access to resources Recommend Favorite